Region: Global
Category: Life Sciences

Global Life Sciences

(45,060 reports matching your criteria)
  • Bone and Joint Health Supplements

    ... Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Joint Supplements, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$14.4 Billion ... Read More

  • Next Generation Sequencers

    ... at a CAGR of 17.3% over the analysis period 2024-2030. Next Generation Sequencer Consumables, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$26.6 Billion by the ... Read More

  • Ion Channel Modulators

    ... at a CAGR of 3.5% over the analysis period 2024-2030. Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$12.4 Billion by the end of ... Read More

  • Parenteral Nutrition

    ... CAGR of 6.8% over the analysis period 2024-2030. Single Dose Amino Acid Solution, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.1 Billion by the end ... Read More

  • Energy based Ablation Devices

    ... 2030, growing at a CAGR of 11.4% over the analysis period 2024-2030. Radiation Technology, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$6.0 Billion by the ... Read More

  • Virtual Reality (VR)

    ... at a CAGR of 17.8% over the analysis period 2024-2030. VR Hardware, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$82.9 Billion by the end of ... Read More

  • Capsule Endoscope Systems

    ... at a CAGR of 5.1% over the analysis period 2024-2030. Small Bowel Capsule, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$426.9 Million by the end ... Read More

  • Industrial Computed Tomography Equipment

    ... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Industrial Computed Tomography Equipment, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$485.4 Million ... Read More

  • Medical Specialty Bags

    ... at a CAGR of 3.7% over the analysis period 2024-2030. Ostomy Bags, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.7 Billion by the end of ... Read More

  • Cardiovascular Catheters

    ... CAGR of 6.6% over the analysis period 2024-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$25.4 Billion by the end of the ... Read More

  • Orthopedic Devices

    ... CAGR of 6.5% over the analysis period 2024-2030. Joint Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$44.6 Billion by the end of the ... Read More

  • Medical Lighting Technologies

    ... at a CAGR of 5.5% over the analysis period 2024-2030. Surgical Lighting Systems, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.2 Billion by the end ... Read More

  • Ophthalmic Instrumentation

    ... CAGR of 4.6% over the analysis period 2024-2030. Ophthalmic Disposables, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More

  • Patient Scales

    ... CAGR of 2.6% over the analysis period 2024-2030. Floor Scales, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$55.8 Million by the end of the analysis ... Read More

  • Peptic Ulcer Testing

    ... at a CAGR of 5.4% over the analysis period 2024-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$410.6 Million by the end of ... Read More

  • Biotechnology Reagents

    ... CAGR of 4.4% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More

  • Microscopes

    ... 5.0% over the analysis period 2024-2030. Optical Microscopes, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More

  • Breast Biopsy Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$983.4 Million by the end ... Read More

  • Bladder Cancer Therapeutics

    ... at a CAGR of 4.4% over the analysis period 2024-2030. Transitional Cell Bladder Cancer Therapeutics, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$114.6 Million by ... Read More

  • Stem Cells

    ... CAGR of 7.4% over the analysis period 2024-2030. Adult Stem Cells, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$17.8 Billion by the end of the ... Read More

  • Anti-Adhesion Products

    ... CAGR of 4.3% over the analysis period 2024-2030. Synthetic Anti-Adhesion Products, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$499.7 Million by the end of the ... Read More

  • Insulin Delivery Systems

    ... at a CAGR of 3.2% over the analysis period 2024-2030. Insulin Delivery Syringes, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$7.0 Billion by the end ... Read More

  • Kidney Stone Management Devices

    ... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end ... Read More

  • Animal Medication

    ... CAGR of 4.5% over the analysis period 2024-2030. Companion Animals Medication, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$20.7 Billion by the end of the ... Read More

  • Commercial Biotechnology Separation Systems

    ... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings